Provenienza dei contatti di primo grado di Duncan McGregor
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Enkefalos Biosciences, Inc.
Enkefalos Biosciences, Inc. BiotechnologyHealth Technology Enkefalos Biosciences, Inc. provides biotechnology services. The CEO of the American company is Duncan McGregor.
2
| Holding Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Duncan McGregor tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Fabrus, Inc.
Fabrus, Inc. BiotechnologyHealth Technology Fabrus, Inc. engages in discovering, developing and engineering therapeutic antibodies. It utilizes multiple proprietary product engines that define a new antibody discovery paradigm. The company is headquartered in San Diego, CA. | Biotechnology | Founder | |
Hiram College | College/University | Undergraduate Degree | |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Corporate Officer/Principal | |
Elizabeth Smider Foundation | Founder | ||
Integrigen, Inc. | Chief Tech/Sci/R&D Officer | ||
Stanford University School of Medicine | College/University | Doctorate Degree | |
Minotaur Therapeutics, Inc.
Minotaur Therapeutics, Inc. BiotechnologyHealth Technology Minotaur Therapeutics is a private biotechnology company that specializes in developing unique biotherapeutics for oncology and immunology. The company is based in San Diego, CA. The company uses the novel ultralong cdr h3 scaffold of bovine antibodies to achieve unique targeting properties. Minotaur has licensing and partnership arrangements with the Applied Biomedical Science Institute and OmniAb on this emerging therapeutic class and its underlying technologies. The CEO of the company is Vaughn V. Smider. | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Settori
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 6 |
Chief Executive Officer | 3 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 2 |
President | 1 |
Contatti più connessi
Insiders | |
---|---|
Vaughn V. Smider | 9 |
Wei Zhao | 1 |
- Borsa valori
- Insiders
- Duncan McGregor
- Connessioni Società